EN ISO 11135-2 – Validation Methods for Ethylene Oxide Sterilization in Biologics
Industries & Services
About Us
At Eurolab, we provide reliable laboratory and certification services according to international standards
Learn More
Our History
Since our establishment, we have gained trust by prioritizing quality and customer satisfaction
Learn More
Mission and Vision
Our mission is to lead with scientific accuracy and objectivity. Our vision is to be a globally recognized pioneer laboratory
Learn More
Why Us?
We stand out with our advanced technology, expert team, and comprehensive service range.
Learn More
Our Quality Policy
We deliver quality services through continuous improvement and a customer-focused approach
Learn More
Our Accreditations
We guarantee the reliability of our services with national and international accreditations
Learn More
Privacy Commitment
Protecting customer information confidentiality and security is our top priority.
Learn More
Contact Us
You can easily reach our expert team for any inquiries or collaborations
Learn More
EN ISO 11135-2 – Validation Methods for Ethylene Oxide Sterilization in Biologics
Validation Methods for Ethylene Oxide Sterilization in Biologics: Understanding EN ISO 11135-2
The biotechnology and pharmaceutical industries rely heavily on effective sterilization methods to ensure the quality and safety of their products. One widely accepted method is ethylene oxide (EtO) sterilization, which has been validated through the development of international standards such as EN ISO 11135-2. This article delves into the real-world applications, testing protocols, and business benefits of this critical laboratory service.
Real-World Applications in the Biotechnology Industry
Biological products, including vaccines, enzymes, and proteins, require sterilization to eliminate microbial contamination. EtO sterilization is a popular choice due to its efficacy against a broad range of microorganisms, including bacteria, viruses, and fungi. This method is particularly useful for heat-sensitive or moisture-sensitive products that cannot withstand other sterilization techniques.
A case study from the biotechnology industry highlights the importance of EN ISO 11135-2 validation. A manufacturer of recombinant protein therapeutics was experiencing inconsistent product yields due to microbial contamination. By implementing EtO sterilization and validating it according to EN ISO 11135-2, the company reduced its microbial contamination rates by 90 and improved overall product quality.
Clear Explanation of How Testing is Performed
The testing protocol for EN ISO 11135-2 involves several steps:
1. Material selection: The type and quantity of materials to be sterilized are determined based on the products requirements.
2. EtO chamber preparation: The EtO chamber is prepared according to the manufacturers instructions, including calibration and verification of the sterilization cycle.
3. Sterilization cycle: The selected material is loaded into the EtO chamber and subjected to a validated sterilization cycle, which includes exposure to EtO gas at a controlled temperature and humidity level.
4. Sampling and analysis: Post-sterilization samples are taken from the load and analyzed for residual EtO levels using techniques such as gas chromatography or mass spectrometry.
5. Validation and documentation: The results of the sterilization cycle, including any adjustments made to the process, are documented and used to validate the effectiveness of the EtO sterilization method.
Risks and Legal Implications of Skipping the Service
Failing to validate an EtO sterilization process according to EN ISO 11135-2 can have severe consequences for biotechnology companies. Non-compliance with this standard may lead to:
1. Product contamination: Inadequate sterilization can result in microbial contamination, compromising product quality and safety.
2. Regulatory non-compliance: Failure to follow established standards can attract regulatory attention, potentially leading to fines, penalties, or even product recalls.
3. Reputation damage: Companies found to be non-compliant with EN ISO 11135-2 may face reputational damage, impacting their ability to attract investors and customers.
Key Commercial Advantages for Clients
Validating an EtO sterilization process according to EN ISO 11135-2 offers several business benefits:
1. Enhanced product quality: Effective sterilization ensures that biological products meet the required standards of safety and purity.
2. Compliance assurance: By following established international standards, companies can demonstrate their commitment to quality and regulatory compliance.
3. Reduced risk exposure: Validation according to EN ISO 11135-2 reduces the risk of product contamination, regulatory non-compliance, and reputational damage.
Practical Considerations for Choosing a Laboratory Partner
When selecting a laboratory partner for EN ISO 11135-2 validation, consider the following factors:
FAQs
Why is validation according to EN ISO 11135-2 necessary for EtO sterilization?
- Validation ensures that the sterilization process is effective and compliant with international standards, reducing the risk of product contamination and regulatory non-compliance.
What are the key differences between EN ISO 11135-1 and EN ISO 11135-2?
- EN ISO 11135-1 focuses on general requirements for EtO sterilization, while EN ISO 11135-2 provides specific guidance for validation methods.
Can any laboratory perform EN ISO 11135-2 validation, or do I need a specialized partner?
- It is recommended to work with a laboratory that has experience in biotechnology testing and is familiar with the requirements of EN ISO 11135-2.
EN ISO 11135-2 – Validation Methods for Ethylene Oxide Sterilization in Biologics
We don't just test we validate your success. Book your testing service and move forward with confidence.
Certification Application